Christopher Michael Chipman - 31 Jan 2022 Form 4/A - Amendment Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Chief Financial Officer
Signature
/s/ Christopher Chipman
Issuer symbol
VRPX
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
25 Feb 2022, 15:43:17 UTC
Date Of Original Report
02 Feb 2022
Next filing
27 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +60,676 $0.000000 60,676 31 Jan 2022 Common Stock 60,676 $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments commencing on January 31, 2023.